191 related articles for article (PubMed ID: 4621955)
1. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Valeriote FA; Tolen SJ
Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
[No Abstract] [Full Text] [Related]
2. [Effect of antineoplastic agents on tumor cells in vivo and in vitro (literature review)].
Merkulov MF; Shelaputina ZF; Leskova SG; Belinskiĭ VA; Talipov ASh
Farmakol Toksikol; 1971; 34(4):490-504. PubMed ID: 4334362
[No Abstract] [Full Text] [Related]
3. Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.
Razek A; Valeriote F; Vietti T
Cancer Res; 1972 Jul; 32(7):1496-500. PubMed ID: 5030578
[No Abstract] [Full Text] [Related]
4. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
van Putten LM; Lelieveld P
Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
[No Abstract] [Full Text] [Related]
5. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.
Letourneau S; Greenbaum M; Cournoyer D
Hum Gene Ther; 1996 May; 7(7):831-40. PubMed ID: 8860835
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
Lilley ER; Rosenberg MC; Elion GB; Colvin OM; Bigner DD; Friedman HS
Cancer Res; 1990 Jan; 50(2):284-7. PubMed ID: 2295068
[TBL] [Abstract][Full Text] [Related]
7. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
[TBL] [Abstract][Full Text] [Related]
9. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
10. [Hemopoietic stem cells and antitumoral drugs. 1. Variations of in vitro and in vivo colony forming cells following single dose administration of cyclophosphamide, vinblastine and azathioprine (author's transl)].
Pannacciulli I; Ghio R; Bogliolo G; Massa G; Saviane A; Bianchi G
Haematologica; 1976 Dec; 61(4):432-8. PubMed ID: 828607
[No Abstract] [Full Text] [Related]
11. Interactions of cytotoxic and anti-inflammatory agents on normal and neoplastic tissue.
Powles TJ; Frank GJ; Millar JL
Adv Prostaglandin Thromboxane Res; 1980; 6():587-9. PubMed ID: 7386294
[No Abstract] [Full Text] [Related]
12. Modulation of alkylating agents by lonidamine in vivo.
Teicher BA; Holden SA; Herman TS; Frei E
Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
[TBL] [Abstract][Full Text] [Related]
13. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of the splenic cells of different mouse strains to the antiproliferative action of alkylating compounds].
Pukhal'skiĭ AL; Mezhneva AP; Pevnitskiĭ LA
Biull Eksp Biol Med; 1988 Feb; 105(2):196-8. PubMed ID: 3349150
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle phase specificity of antitumor agents.
Bhuyan BK; Scheidt LG; Fraser TJ
Cancer Res; 1972 Feb; 32(2):398-407. PubMed ID: 4258018
[No Abstract] [Full Text] [Related]
16. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
Phelan ET; Vietti TJ; Valeriote FA; Coulter D
Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
[TBL] [Abstract][Full Text] [Related]
17. [Effect of some alkylating agents and whole-body ionizing radiation on the formation and realization of immunologic memory].
Kazarian KA; Fontalin LN; Pevnitskiĭ LA; Solov'ev VV
Biull Eksp Biol Med; 1971 Nov; 72(11):58-61. PubMed ID: 5002198
[No Abstract] [Full Text] [Related]
18. The mechanisms of action of antitumor compounds.
Belousova AK
Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
[No Abstract] [Full Text] [Related]
19. Differential effects of melphalan on mouse myeloma (adj. PC-5) and hemopoietic stem cells.
Ogawa M; Bergsagel DE; McCulloch EA
Cancer Res; 1971 Dec; 31(12):2116-9. PubMed ID: 5120302
[No Abstract] [Full Text] [Related]
20. Effects of antileukemic agents on the respiratory activity of murine lymphocytic Leukemia L1210.
Goodman MT; Folk RM; Ackerman GA
J Natl Cancer Inst; 1973 Sep; 51(3):917-28. PubMed ID: 4743561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
